40 results
10-K
2023 FY
EX-10.16
FENC
Fennec Pharmaceuticals Inc
Annual report
29 Mar 24
4:14pm
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K/A
EX-10.1
FENC
Fennec Pharmaceuticals Inc
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-10.1
a2higtrrbcxp jg6q6pt
1 Aug 22
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
4:15pm
8-K
EX-10.1
tfy707 ze5qrv
31 Jan 22
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.1
nghnn2
24 Jun 21
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
12:02pm
8-K
EX-10.1
i4mnhl i2
26 Jun 20
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
4:13pm
8-K
EX-10.1
cd5qr76bxb6
9 Sep 19
Fennec Appoints Shubh Goel As Chief Commercial Officer
4:13pm
8-K
EX-10.1
ov6u0a8 vmhckn
20 Jun 19
Departure of Directors or Certain Officers
6:03am
8-K
EX-10.1
8fpjqrih3ot59uv
4 Feb 19
Fennec Pharmaceuticals Announces $12.5 Million Debt Financing with Bridge Bank
2:26pm
8-K
EX-10.1
hbhr6k
29 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.23
6d5uc4iaibt8qd18pl7s
20 Jun 13
Departure of Directors or Certain Officers
12:00am